Skip to Content
Morningstar

Fresenius SE & Co KGaA FRE

Morningstar Rating
Unlock
Stock XETR Rating as of
€27.52 −0.23 (0.83%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Price vs Fair Value

View History
FRE is trading at a 331% premium.
Price
€27.75
Fair Value
€52.00
Uncertainty
High
1-Star Price
€16.70
5-Star Price
€14.00
Economic Moat
Vvrgln
Capital Allocation
Gbcgxhr

Bulls Say, Bears Say

Bulls

Underlying demographic trends and international expansion opportunities should keep Fresenius’ dialysis services and related medical product growth in positive territory as the pandemic recedes.

Bears

Until the US achieves universal affordable coverage, policy risks around reimbursement for dialysis services may continue to add risk to the story.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FRE is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
€27.75
Day Range
€27.26–27.71
52-Week Range
€23.93–31.22
Bid/Ask
€0.00 / €27.52
Market Cap
€15.50 Bil
Volume/Avg
811,271 / 1.2 Mil

Key Statistics

Price/Earnings (Normalized)
6.28
Price/Sales
0.71
Dividend Yield (Trailing)
3.32%
Dividend Yield (Forward)
—
Total Yield
3.32%

Company Profile

Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Large Value
Total Number of Employees
193,865
Website
https://www.fresenius.com

Competitors

Valuation

View More
Metric
FRE
ICUI
DVA
Price/Earnings (Normalized)
 6.2817.7714.87
Price/Book Value
 0.831.2512.93
Price/Sales
 0.711.141.03
Price/Cash Flow
 9.309.426.36
Price/Earnings
FRE
ICUI
DVA

Financial Strength

Metric
FRE
ICUI
DVA
Quick Ratio
 0.640.921.06
Current Ratio
 1.342.611.19
Interest Coverage
 2.12−0.053.95
Quick Ratio
FRE
ICUI
DVA

Profitability

Metric
FRE
ICUI
DVA
Return on Assets (Normalized)
 2.15%3.32%6.99%
Return on Equity (Normalized)
 7.52%6.94%118.17%
Return on Invested Capital (Normalized)
 3.57%5.84%10.75%
Return on Assets
FRE
ICUI
DVA
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Care Facilities Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA
HCA Healthcare IncGrjsvmcQjspf$85.1 Bil
FSNUY
Fresenius SE & Co KGaA ADR—Jqgmgp$17.0 Bil
FSNUF
Fresenius SE & Co KGaA—Cnbpzz$17.0 Bil
FMS
Fresenius Medical Care AG ADRDzxpySyzcgp$12.9 Bil
FMCQF
Fresenius Medical Care AG—Hdblwk$12.9 Bil
BDUUY
Bangkok Dusit Medical Services PCL ADR—Vwl$12.9 Bil
BDUUF
Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt—Wthj$12.9 Bil
THC
Tenet Healthcare CorpZjthgctnbSznz$12.5 Bil
DVA
DaVita IncTsyqvfwwtJlzjzg$12.4 Bil
AMN
AMN Healthcare Services IncPrjmlqpYztsgkg$2.3 Bil

Sponsor Center